Pluristem Therapeutics Inc.

Pluristem Therapeutics Inc.verified

PSTI

Price:

$1

Market Cap:

$40.85M

Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also d...[Read more]

Industry

Biotechnology

IPO Date

2007-12-10

Stock Exchange

NASDAQ

Ticker

PSTI

The Enterprise Value as of November 2025 (TTM) for Pluristem Therapeutics Inc. (PSTI) is 43.29M

According to Pluristem Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 43.29M. This represents a change of -27.72% compared to the average of 59.89M of the last 4 quarters.

Pluristem Therapeutics Inc. (PSTI) Historical Enterprise Value (quarterly & annually)

How has PSTI Enterprise Value performed in the past?

The mean historical Enterprise Value of Pluristem Therapeutics Inc. over the last ten years is 122.57M. The current 43.29M Enterprise Value has changed 3.43% with respect to the historical average. Over the past ten years (40 quarters), PSTI's Enterprise Value was at its highest in in the September 2020 quarter at 263.70M. The Enterprise Value was at its lowest in in the December 2024 quarter at 11.05M.

Quarterly (TTM)
Annual

Average

122.57M

Median

113.77M

Minimum

64.24M

Maximum

193.67M

Pluristem Therapeutics Inc. (PSTI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pluristem Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 124.56%

Maximum Annual Enterprise Value = 193.67M

Minimum Annual Increase = -42.95%

Minimum Annual Enterprise Value = 64.24M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202564.24M-38.63%
2021104.67M-32.11%
2020154.18M124.56%
201968.66M-42.95%
2018120.35M12.27%
2017107.20M7.66%
201699.58M-35.55%
2015154.49M-20.23%
2014193.67M22.07%
2013158.66M111.85%

Pluristem Therapeutics Inc. (PSTI) Average Enterprise Value

How has PSTI Enterprise Value performed in the past?

The current Enterprise Value of Pluristem Therapeutics Inc. (PSTI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

107.70M

5-year avg

102.42M

10-year avg

122.57M

Pluristem Therapeutics Inc. (PSTI) Enterprise Value vs. Peers

How is PSTI’s Enterprise Value compared to its peers?

Pluristem Therapeutics Inc.’s Enterprise Value is greater than Magenta Therapeutics, Inc. (-12257976.00), greater than Rein Therapeutics Inc. (31.70M), greater than Eyenovia, Inc. (38.86M), greater than Satsuma Pharmaceuticals, Inc. (20.18M), greater than Lumos Pharma, Inc. (24.19M), greater than Lunai Bioworks Inc. (35.00M), less than GreenLight Biosciences Holdings (57.81M), greater than Cerecor Inc. (-3660587.00), greater than LianBio (-40025352.00), less than AlloVir, Inc. (69.87M),

CompanyEnterprise ValueMarket cap
-12257976.00$42.44M
31.70M$35.75M
38.86M$38.59M
20.18M$36.47M
24.19M$37.54M
35.00M$32.92M
57.81M$45.43M
-3660587.00$38.63M
-40025352.00$11.68M
69.87M$49.48M

Build a custom stock screener for Pluristem Therapeutics Inc. (PSTI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pluristem Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pluristem Therapeutics Inc. (PSTI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pluristem Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Pluristem Therapeutics Inc.'s Enterprise Value?

What is the highest Enterprise Value for Pluristem Therapeutics Inc. (PSTI)?

What is the 3-year average Enterprise Value for Pluristem Therapeutics Inc. (PSTI)?

What is the 5-year average Enterprise Value for Pluristem Therapeutics Inc. (PSTI)?

How does the current Enterprise Value for Pluristem Therapeutics Inc. (PSTI) compare to its historical average?